does medi-cal cover glp-1 drugs GLP-1s prescriptions for weight loss are skyrocketing in North Carolina California Medi-Cal halts GLP-1 obesity

In total, 1,797 patients (56.5%) had established CV disease without CKD, 354 patients (11.1%) had CKD only, and 544 patients (17.1%) had both CV disease and CKD

Cell Mol Neurobiol 37(4):607617

Consistency in measurement method matters more than absolute accuracy

"The FDA's compounding program aims to protect patients from poor quality compounded drugs, while preserving access to lawfully marketed compounded drugs for patients." Compound versions of drugs -- made for individual patients using raw ingredients -- are not required to go through the FDA's rigorous approval process

doi:10.1016/b978-0-12-822218-8.00002-8